The DOI matches its Crossref record; 239 of the 241 references it cites were found in a registry or an index.
Notch receptor/ligand diversity: contribution to colorectal cancer stem cell heterogeneity
Open accessAbstract
Cancer cell heterogeneity is a key contributor to therapeutic failure and post-treatment recurrence. Targeting cell subpopulations responsible for chemoresistance and recurrence seems to be an attractive approach to improve treatment outcome in cancer patients. However, this remains challenging due to the complexity and incomplete characterization of tumor cell subpopulations. The heterogeneity of cells exhibiting stemness-related features, such as self-renewal and chemoresistance, fuels this complexity. Notch signaling is a known regulator of cancer stem cell (CSC) features in colorectal cancer (CRC), though the effects of its heterogenous signaling on CRC cell stemness are only just emerging. In this review, we discuss how Notch ligand-receptor specificity contributes to regulating stemness, self-renewal, chemoresistance and cancer stem cells heterogeneity in CRC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The Notch signaling pathway plays a significant role in CSC self-renewal and cell fate decisions, and dysregulated Notch signaling contributes to CRC progression, chemoresistance, and CSC heterogeneity [196].”
From Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer (2025) · cites this paper as [196]
The cited source says what the claim attributes to it.
In the citing paper
“Neutralizing mAbs targeting Notch receptors or ligands, such as delta ligand-4 (DLL4), have also been developed to block Notch signaling and were reported to reduce colorectal CSC self-renewal and tumor growth in vivo [196].”
From Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer (2025) · cites this paper as [196]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Nowell, P. C. (1976) · Science · doi:10.1126/science.959840 · Cited by 6,471
Notch Signaling: Cell Fate Control and Signal Integration in Development
Artavanis-Tsakonas, S., Rand, M. D., & Lake, R. J. (1999) · Science · doi:10.1126/science.284.5415.770 · Cited by 5,909
5-Fluorouracil: mechanisms of action and clinical strategies
Longley, D. B., Harkin, D. P., & Johnston, P. G. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1074 · Cited by 5,332
The consensus molecular subtypes of colorectal cancer
Guinney, J., Dienstmann, R., Wang, X., de Reyniès, A., Schlicker, A., Soneson, C., Marisa, L., Roepman, P., Nyamundanda, G., Angelino, P., et al. (2015) · Nature Medicine · doi:10.1038/nm.3967 · Cited by 5,170
The Canonical Notch Signaling Pathway: Unfolding the Activation Mechanism
Kopan, R., & Ilagan, M. X. G. (2009) · Cell · doi:10.1016/j.cell.2009.03.045 · Cited by 3,643
ESMO consensus guidelines for the management of patients with metastatic colorectal cancer
Van Cutsem, E., Cervantes, A., Adam, R., Sobrero, A., Van Krieken, J. H., Aderka, D., Aranda Aguilar, E., Bardelli, A., Benson, A., Bodoky, G., et al. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw235 · Cited by 3,421
Greaves, M., & Maley, C. C. (2012) · Nature · doi:10.1038/nature10762 · Cited by 3,162
A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
Sharma, S. V., Lee, D. Y., Li, B., Quinlan, M. P., Takahashi, F., Maheswaran, S., McDermott, U., Azizian, N., Zou, L., Fischbach, M. A., et al. (2010) · Cell · doi:10.1016/j.cell.2010.02.027 · Cited by 2,770
Brenner, H., Kloor, M., & Pox, C. P. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61649-9 · Cited by 2,762
Research works printed but not linked: 1
- Huang, Colorectal cancer stem cell and chemoresistant colorectal cancer cell phenotypes and increased sensitivity to Notch pathway inhibitor, Mol. Med. Rep., 12, 2417, 10.3892/mmr.2015.3694 · DOI
Cited by
Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer
Haynes, J., & Manogaran, P. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26051988 · Cited by 82
“The Notch signaling pathway plays a significant role in CSC self-renewal and cell fate decisions, and dysregulated Notch signaling contributes to CRC progression, chemore-sistance, and CSC heterogeneity [196].”
The Impact of Cancer Stem Cells in Colorectal Cancer
Radu, P., Zurzu, M., Tigora, A., Paic, V., Bratucu, M., Garofil, D., Surlin, V., Munteanu, A. C., Coman, I. S., Popa, F., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25084140 · Cited by 30
Sun, J., Chen, Y., Xu, Z., Wang, W. W., & Li, P. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06282-z · Cited by 30
Parry, R. A., Mir, I. A., Bhat, B. A., Hussain, M. U., Ashraf, S., Zaman, G. S., Bashir, N., Vats, S., & Ganie, S. A. (2025) · Scientific Reports · doi:10.1038/s41598-025-89714-6 · Cited by 10
A dynamic molecular landscape in colorectal cancer progression at single-cell resolution
Sheng, J., Li, N., Li, S., Ye, Y., Liao, Y., Zhang, Y., Chen, H., Tu, M., Zhong, G., Xiong, C., et al. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06785-9 · Cited by 10
Metadata
- Authors
- Brisset, M., Mehlen, P., Meurette, O., & Hollande, F.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- The University of Melbourne (AU)
- Corresponding author
- Hollande, Frédéric
- Venue
- Frontiers in Cell and Developmental Biology
- Publisher
- Frontiers Media SA
- Published
- 2023-10-04
- Volume
- 11
- Pages
- 1231416-1231416
- ISSN
- 2296-634X (ISSN-L)
- PMC
- PMC10582728
- OpenAlex
- W4387335582
- Cited by
- 20
- References
- 241
- Citations by year
- 2026: 7 · 2025: 12 · 2024: 1
- FWCI
- 0.65
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Cell and Developmental Biology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
- Keywords
- Notch signaling, Notch receptor, Notch ligands, colorectal cancer, cancer stem cells, tumor heterogeneity, chemoresistance, self-renewal, stemness
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Notch receptor/ligand diversity: contribution to colorectal cancer stem cell heterogeneity. https://app.cochat.ai/papers/10.3389/fcell.2023.1231416
- The paper
- Brisset, M., Mehlen, P., Meurette, O., & Hollande, F. (2023). Notch receptor/ligand diversity: contribution to colorectal cancer stem cell heterogeneity. Frontiers in Cell and Developmental Biology. https://doi.org/10.3389/fcell.2023.1231416
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.